GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
- Conditions
- First Posted Date
- 2005-09-26
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 140
- Registration Number
- NCT00225862
- Locations
- 🇺🇸
GSK Investigational Site, Wenatchee, Washington, United States
Long Term Safety Of GW685698X Via Nasal Biopsy
- Conditions
- Interventions
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 125
- Registration Number
- NCT00224523
- Locations
- 🇳🇱
GSK Investigational Site, Nijmegen, Netherlands
A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium
- Conditions
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 120
- Registration Number
- NCT00224510
- Locations
- 🇪🇸
GSK Investigational Site, Valencia, Spain
A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease
- Conditions
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2009-12-24
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 380
- Registration Number
- NCT00224497
- Locations
- 🇪🇸
GSK Investigational Site, Tarrasa, Barcelona, Spain
Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 671
- Registration Number
- NCT00224471
- Locations
- 🇨🇦
GSK Investigational Site, Beauport, Quebec, Canada
Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
- Conditions
- Interventions
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2019-01-07
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 5960
- Registration Number
- NCT00224484
- Locations
- 🇬🇧
GSK Investigational Site, Sheffield, United Kingdom
Treatment Of Symptomatic Asthma In Children
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 176
- Registration Number
- NCT00197106
- Locations
- 🇳🇱
GSK Investigational Site, Zwolle, Netherlands
In-Patient Study In Schizophrenic Patients
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2009-05-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 60
- Registration Number
- NCT00197093
Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 521
- Registration Number
- NCT00197002
- Locations
- 🇺🇸
GSK Investigational Site, Vancouver, Washington, United States
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2018-08-20
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 468
- Registration Number
- NCT00197236
- Locations
- 🇺🇸
GSK Investigational Site, La Crosse, Wisconsin, United States